VistaGen Therapeutics, Inc.VTGNNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -34.17% | -43.12% | -107.60% | +190.48% | +40.98% |
| Gross Profit Growth | -34.17% | -43.12% | -107.60% | -10.71% | +40.98% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +205.03% | +108.95% | +13.62% | +4.34% | +16.70% |
| Weighted Average Shares Diluted Growth | +205.03% | +108.95% | +13.62% | +4.34% | +16.70% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +142.91% | -29.57% | -31.79% | -39.30% | -21.04% |
| Book Value per Share Growth | -14.49% | -68.51% | -45.79% | -48.09% | -38.86% |
| Debt Growth | -24.60% | -24.03% | -28.82% | +18.39% | +3.96% |
| R&D Expense Growth | +165.26% | +149.14% | +37.25% | +52.69% | +55.80% |
| SG&A Expenses Growth | +30.81% | +7.74% | +3.71% | -4.31% | +4.79% |